Search Results - "Dobogai, L.C"

230: Fludarabine/full dose I.V. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patients by Chunduri, S, Dobogai, L.C, Peace, D, Saunthararajah, Y, Quigley, J, Chen, Y.-H, Boccuni, P, Hoffman, R, Mahmud, N, Beri, R, Hurter, E, Rondelli, D

Get full text

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen by Beri, R, Chunduri, S, Sweiss, K, Peace, D J, Mactal-Haaf, C, Dobogai, L C, Shord, S, Quigley, J G, Chen, Y H, Mahmud, N, Rondelli, D

“…A pretransplant test dose of i.v. BU was previously used in pediatric patients undergoing a reduced-intensity allogeneic hematopoietic SCT (HSCT). Here, we…”
Get full text

Fludarabine i.v. BU conditioning regimen: myeloablative, reduced intensity or both? by Chunduri, S, Dobogai, L C, Peace, D, Saunthararajah, Y, Quigley, J, Chen, Y-H, Mahmud, N, Hurter, E, Beri, R, Rondelli, D

“…In this study, we utilized a conditioning regimen with fludarabine and myeloablative dose i.v. BU (12.8 mg/kg) (FluBU) in 36 adult patients (median age: 44…”
Get full text